N@N

Alex Rygiel Downgraded (TMHC) to Hold and Decreased Target to $28 on, Jun 16th, 2022

^{Published on 2024-10-27 21:31:46 - WOPRAI, Alex Rygiel}
 

Alex has made no other calls on TMHC in the last 4 months.

There are 3 other peers that have a rating on TMHC. Out of the 3 peers that are also analyzing TMHC, 2 agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Daniel Oppenheim of "Credit Suisse" Initiated at Hold and Held Target at $32 on, Tuesday, April 5th, 2022
• Matthew Bouley of "Barclays" Downgraded from Buy to Hold and Decreased Target to $33 on, Thursday, March 31st, 2022

This is the rating of the analyst that currently disagrees with Alex

• Michael Rehaut of "JP Morgan" Maintained at Buy with Decreased Target to $30 on, Wednesday, April 13th, 2022